Sec Form 4 Filing - Dallas H James @ MEDTRONIC INC - 2013-06-19

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Dallas H James
2. Issuer Name and Ticker or Trading Symbol
MEDTRONIC INC [ MDT]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
SrVP Quality, Operations, IT
(Last) (First) (Middle)
710 MEDTRONIC PKWY MS LC300
3. Date of Earliest Transaction (MM/DD/YY)
06/19/2013
(Street)
MINNEAPOLIS, MN55432
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/19/2013 M 35,872 A $ 36.24 151,700.603 D
Common Stock 06/19/2013 M 25,056 A $ 35.92 176,756.603 D
Common Stock 06/19/2013 M 17,746 A $ 37.53 194,502.603 D
Common Stock 06/19/2013 M 11,468 A $ 34.88 205,970.603 D
Common Stock 06/19/2013 S 200 D $ 52.08 205,770.603 D
Common Stock 06/19/2013 S 12,304 ( 2 ) D $ 52.7699 193,466.603 D
Common Stock 06/19/2013 S 2,789 ( 3 ) D $ 52.0794 190,677.603 D
Common Stock ( 4 ) 06/1 9/2013 S 78,824 ( 5 ) D $ 52.7556 111,853.603 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $ 36.24 06/19/2013 M 35,872 10/27/2009( 1 ) 10/27/2018 Common Stock 35,872 $ 0 0 D
Employee Stock Option (right to buy) $ 35.92 06/19/2013 M 25,056 08/03/2010( 1 ) 08/03/2019 Common Stock 25,056 $ 0 8,352 D
Employee Stock Option (right to buy) $ 37.53 06/19/2013 M 17,746 08/02/2011( 1 ) 08/02/2020 Common Stock 17,746 $ 0 17,746 D
Employee Stock Option (right to buy) $ 34.88 06/19/2013 M 11,468 08/01/2012( 1 ) 08/01/2021 Common Stock 11,468 $ 0 34,404 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Dallas H James
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS, MN55432
SrVP Quality, Operations, IT
Signatures
Rhonda L. Ingalsbe, Attorney-in-fact 06/20/2013
Signature of Reporting Person Date
Explanation of Responses:
( 1 )These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
( 2 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.12 to $53.10, inclusive. The reporting person undertakes to provide to Medtronic, any security holder of Medtronic, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), and (5) to this Form 4.
( 3 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.0624 to $52.11 inclusive.
( 4 )This balance increased by 1204.84 shares due to exempt transactions such as dividend reinvestment and ESPP.
( 5 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.13 to $53.11,inclusive.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.